iDose® TR (travoprost intracameral implant) – New drug approval
December 14, 2023 - Glaukos announced the FDA approval of iDose TR (travoprost intracameral implant), for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Download PDF
